Joint Pharmaceutical Analysis Group (joint with RPS)

The Joint Pharmaceutical Analysis Group (JPAG) is one of the RSC's many Interest Groups and is joint with the Royal Pharmaceutical Society.

The identification of distinct protective and susceptibility mechanisms for hip osteoarthritis: findings from a genome-wide association study meta- analysis of minimum joint space width and Mendelian randomisation cluster analyses - eBioMedicine

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Reusable and Porous Skin Patches with Thermopneumatic Adhesion Control Capability and High Water Vapor Permeability

JPAG - Joint Pharmaceutical Analysis Group (@JpagGroup) / X

Using Data Analysis To Evaluate and Compare Chemical Syntheses

High-Quality CBD Balms Experience the Muscle MX Difference

Energies, Free Full-Text

Parallel artificial liquid membrane extraction coupled with UPLC-ESI-MS/MS method for high-throughput quantitation of repaglinide in diabetic patients - ScienceDirect

A meta-proteomics approach to study the interspecies interactions affecting microbial biofilm development in a model community

Cloudflare mitigated 89 hyper-volumetric HTTP distributed DDoS attacks exceeding 100 million rps

RSK-3 promotes cell proliferation by regulating rpS6 and autophagy.